about
Sperm protein 17 is expressed in human nervous system tumours.Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines.Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.Immunological treatment of liver tumorsAdvances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.Immunoinformatics and modeling perspective of T cell epitope-based cancer immunotherapy: a holistic picture.Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond.Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.Cancer-testis antigens and immunotherapy in the light of cancer complexity.Cancer initiation and progression: an unsimplifiable complexity.ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers.The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myelomaComment on 'Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'.Rethinking immunotherapy for brain cancers in the light of cancer complexity.
P2860
Q25256674-140D15A5-7975-4E74-9E9C-C6B665428158Q34111850-42E00257-3947-4079-A175-EA76D3CD2B23Q35633563-54084021-1273-44C4-A6AF-258519232FE2Q36373254-FD3F2887-21EF-4401-9499-932B7A63970AQ36844954-7799419A-67C5-41AC-B764-6D68A6DBDD0EQ37606469-0650E4E2-A813-4D08-AC8B-11D60668A886Q37873931-71CA0D21-361B-4867-A39B-C573E9F2C780Q38212231-2E389F58-C764-4A39-967C-86E109F12D5AQ38435410-F1CCF8F5-24D7-48A8-908E-0DE184320A51Q38818604-BF242043-FBE4-4F37-BC0E-863801246F81Q39617457-5CF5CACB-7B02-47C5-A0CF-EA25FD9051B3Q39995720-752FCED2-C18D-478E-A9A4-3F60DEB0FACAQ41512508-871D5E8A-CABA-47DD-9A3B-5543E73014C0Q42539488-FA0D57E3-6AF7-4491-99F8-CB31DF02FC6E
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cancer immunotherapy: avoiding the road to perdition
@ast
Cancer immunotherapy: avoiding the road to perdition
@en
Cancer immunotherapy: avoiding the road to perdition
@nl
type
label
Cancer immunotherapy: avoiding the road to perdition
@ast
Cancer immunotherapy: avoiding the road to perdition
@en
Cancer immunotherapy: avoiding the road to perdition
@nl
prefLabel
Cancer immunotherapy: avoiding the road to perdition
@ast
Cancer immunotherapy: avoiding the road to perdition
@en
Cancer immunotherapy: avoiding the road to perdition
@nl
P2093
P2860
P3181
P356
P1476
Cancer immunotherapy: avoiding the road to perdition
@en
P2093
Fabio Grizzi
Maurizio Chiriva-Internati
Robert K Bright
W Martin Kast
P2860
P2888
P3181
P356
10.1186/1479-5876-2-26
P577
2004-07-29T00:00:00Z
P5875
P6179
1036012329